Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Coy

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 11, 2020
Lysosomal Biogenesis and Implications for Hydroxychloroquine DispositionKeagan P Collins, Sandra Witta, Jonathan W Coy, et al.
Journal of Feline Medicine and Surgery|December 4, 2016
Comparison of proliferative and immunomodulatory potential of adipose-derived mesenchymal stem cells from young and geriatric catsLara B Zajic, Tracy L Webb, Polly Webb, et al.
Stem Cells and Development|November 16, 2016
Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical PathwaysWilliam H Wheat, Lyndah Chow, Jade N Kurihara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2019
The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte RecruitmentDaniel P Regan, Jonathan W Coy, Kirti Kandhwal Chahal, et al.
Veterinary Dermatology|August 25, 2018
Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogsClarissa P Souza, Jennifer R Schissler, Elena T Contreras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2021
Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic OsteosarcomaDaniel P Regan, Lyndah Chow, Sunetra Das, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|November 11, 2020
Lysosomal Biogenesis and Implications for Hydroxychloroquine DispositionKeagan P Collins, Sandra Witta, Jonathan W Coy, et al.
Journal of Feline Medicine and Surgery|December 4, 2016
Comparison of proliferative and immunomodulatory potential of adipose-derived mesenchymal stem cells from young and geriatric catsLara B Zajic, Tracy L Webb, Polly Webb, et al.
Stem Cells and Development|November 16, 2016
Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical PathwaysWilliam H Wheat, Lyndah Chow, Jade N Kurihara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2019
The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte RecruitmentDaniel P Regan, Jonathan W Coy, Kirti Kandhwal Chahal, et al.
Veterinary Dermatology|August 25, 2018
Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogsClarissa P Souza, Jennifer R Schissler, Elena T Contreras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2021
Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic OsteosarcomaDaniel P Regan, Lyndah Chow, Sunetra Das, et al.
Pageof 1